Log in to save to my catalogue

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effectiv...

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effectiv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7eccea89fef54fdfadb06b2ab6ab804f

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy

About this item

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Active targeting by surface-modified nanoplatforms enables a more precise and elevated accumulation of nanoparticles within the tumor, thereby enhancing drug delivery and efficacy for a successful cancer treatment. However, surface functionalization involves complex procedures that increase costs and timelines, presenting challenges for clinical im...

Alternative Titles

Full title

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7eccea89fef54fdfadb06b2ab6ab804f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7eccea89fef54fdfadb06b2ab6ab804f

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-024-01997-x

How to access this item